Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemoradiotherapy, Adjuvant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT04135664
What this trial is testing

Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Shanghai Chest Hospital 176
Testing effectiveness (Phase 2)Study completedNCT00059826
What this trial is testing

Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 89
Large-scale testing (Phase 3)Looking for participantsNCT05735145
What this trial is testing

Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsChemoradiotherapyAdjuvant Chemotherapy
Fourth Affiliated Hospital of Guangxi Medical University 108
Testing effectiveness (Phase 2)Ended earlyNCT04016142
What this trial is testing

Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer

Who this might be right for
Locally Advanced CancerCervical Cancer
Centre Oscar Lambret 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03141359
What this trial is testing

Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC

Who this might be right for
Lung Cancer Stage IILung Cancer Stage IIINon Small Cell Lung Cancer
Wake Forest University Health Sciences 61
Testing effectiveness (Phase 2)Study completedNCT00340184
What this trial is testing

A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients

Who this might be right for
Cervical Cancer
Korean Gynecologic Oncology Group 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07836049
What this trial is testing

PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Vanderbilt-Ingram Cancer Center 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06998719
What this trial is testing

Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIIBorderline Resectable Carcinoma
Bi Nan 80
Large-scale testing (Phase 3)Study completedNCT00424255
What this trial is testing

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Who this might be right for
Neoplasms, Head and Neck
GlaxoSmithKline 688
Testing effectiveness (Phase 2)Active Not RecruitingNCT02931890
What this trial is testing

Multicentric Randomised Trial for Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
The Netherlands Cancer Institute 207
Testing effectiveness (Phase 2)Study completedNCT00858338
What this trial is testing

Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer

Who this might be right for
Gastric CancerStomach Cancer
NYU Langone Health 28
Testing effectiveness (Phase 2)Study completedNCT01218048
What this trial is testing

ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Robert Ferris 40
Testing effectiveness (Phase 2)Study completedNCT03984357
What this trial is testing

Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 152
Not applicableStudy completedNCT00994721
What this trial is testing

A Phase III Study of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Health Research Institutes, Taiwan 147
Testing effectiveness (Phase 2)Study completedNCT00609336
What this trial is testing

Perioperative Therapy for Resectable Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage IA Pancreatic CancerStage IB Pancreatic Cancer+2 more
University of Washington 35
Not applicableEnded earlyNCT03402477
What this trial is testing

"Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.

Who this might be right for
Rectal Cancer
Helse Stavanger HF 86
Testing effectiveness (Phase 2)Study completedNCT01797900
What this trial is testing

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Who this might be right for
Nasopharyngeal Neoplasms
Chinese Academy of Medical Sciences 130
Not applicableStudy completedNCT02994264
What this trial is testing

Compare Adjuvant Concurrent Chemoradiation (CCRT) to Adjuvant Radiation Therapy (RT) in Grade 2 and 3 Extremity Soft Tissue Sarcomas

Who this might be right for
Sarcoma,Soft Tissue
Institut de Cancérologie de Lorraine 80
Not applicableStudy completedNCT02312284
What this trial is testing

Observational Study on the Patients With Rectal Cancer

Who this might be right for
Rectal CancerAdjuvant ChemoradiotherapyNeoadjuvant Chemoradiotherapy+2 more
Chinese Academy of Medical Sciences 3,995
Not applicableEnrolling By InvitationNCT06997913
What this trial is testing

Adjuvant Immunotherapy Combined With ChemoRadiation for Patients With High-risk Resectable Extrahepatic Cholangiocarcinoma（AICRC）

Who this might be right for
Lymph Node MetastasisNeurovascular InvasionPathology Showed R1 Resection
Hengchao Yu 10
Next Page